Peter M. O’Neill

Cellectis, New York, NY, United States

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

ByGen Li, PhD, MBA,Jonathan Peachey,Paul Chew, MD,Peter M. O’Neill

May 26th 2023

Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.

Peter M. O’Neill

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

Latest Updated Articles

Trending on Applied Clinical Trials Online

FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains

Inside the Recruitment Bottlenecks Driving Trial Delays

Designing Feasible Protocols with Real-World Data

Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity

ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation